03rd week of 2017 patent applcation highlights part 7 |
Patent application number | Title | Published |
20170014371 | SARMS AND METHOD OF USE THEREOF | 2017-01-19 |
20170014372 | Drug Combination for Treatment of Proliferative Diseases | 2017-01-19 |
20170014373 | METHODS OF TREATING CANCER | 2017-01-19 |
20170014374 | COMPOSITION FOR TREATMENT OF DYSLIPIDEMIA AND INFLAMMATION | 2017-01-19 |
20170014375 | PHARMACEUTICAL COMPOSITION COMPRISING EFFECTIVE DOSE OF POMIFERIN FOR TREATING CANCERS | 2017-01-19 |
20170014376 | SYSTEMS, METHODS, AND FORMULATIONS FOR TREATING CANCER | 2017-01-19 |
20170014377 | ANTHOCYANIDIN COMPLEX | 2017-01-19 |
20170014378 | COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS | 2017-01-19 |
20170014379 | Pharmaceutical Formulations of Vildagliptin | 2017-01-19 |
20170014380 | Vildagliptin Formulation Process Under Inert Gas Atmosphere | 2017-01-19 |
20170014381 | NEW SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS | 2017-01-19 |
20170014382 | SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES | 2017-01-19 |
20170014383 | SOLID DISPERSION OF INDIRUBIN | 2017-01-19 |
20170014384 | METHOD FOR INHIBITING TUMOR METASTASIS | 2017-01-19 |
20170014385 | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF HALLUCINATIONS ASSOCIATED WITH A NEURODEGENERATIVE DISEASE | 2017-01-19 |
20170014386 | Treatment of Multidrug-Resistant Nephrotic Syndrome (MDR-NS) in Children | 2017-01-19 |
20170014387 | Methods of Reducing Mammographic Breast Density and/or Breast Cancer Risk | 2017-01-19 |
20170014388 | CARBOXAMIDE DERIVATIVES | 2017-01-19 |
20170014389 | INHALABLE AZTREONAM LYSINATE FORMULATION FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS | 2017-01-19 |
20170014390 | TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILAST | 2017-01-19 |
20170014391 | SGK1 INHIBITORS FOR TREATMENT OF PROSTATE CANCER | 2017-01-19 |
20170014392 | METHODS OF TREATING DEVELOPMENTAL DISORDERS USING GABOXADOL | 2017-01-19 |
20170014393 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL | 2017-01-19 |
20170014394 | THIENOPYRIDINE DERIVATIVE FOR THE TREATMENT OF HEPATITIS C INFECTIONS | 2017-01-19 |
20170014395 | ENDOPARASITE CONTROL AGENT AND METHOD FOR USING THE SAME | 2017-01-19 |
20170014396 | PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS | 2017-01-19 |
20170014397 | IRON CHELATORS FOR TREATING AND PREVENTING CELL DEATH AND ORGAN DAMAGE FOLLOWING AN ISCHEMIC EVENT | 2017-01-19 |
20170014398 | TOPICAL RETINOID COMPOSITIONS | 2017-01-19 |
20170014399 | ANDROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND ANDROGEN RECEPTOR-ASSOCIATED DISEASES | 2017-01-19 |
20170014400 | METHOD OF TREATING OR PREVENTING HYPERLIPIDEMIA WITH CAFFEAMIDE DERIVATIVES | 2017-01-19 |
20170014401 | NUCLEAR RECEPTOR BINDING AGENTS | 2017-01-19 |
20170014402 | METHODS AND COMPOSITIONS FOR TREATING CANCER THROUGH INHIBITION OF PI3K | 2017-01-19 |
20170014403 | Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity | 2017-01-19 |
20170014404 | SUSTAINED RELEASE FORMULATION OF NALTREXONE | 2017-01-19 |
20170014407 | PYRIDAZINE DERIVATIVES FOR USE IN THE PREVENTON OR TREATMENT OF AN ATAXIC DISORDER | 2017-01-19 |
20170014408 | HEPATITIS B ANTIVIRAL AGENTS | 2017-01-19 |
20170014409 | TREATING INFLAMMATION USING SERELAXIN | 2017-01-19 |
20170014410 | TREATMENT OF PROLIFERATIVE DISORDERS WITH A CHEMILUMINESCENT AGENT | 2017-01-19 |
20170014411 | FLUOROCYCLOPENTENYLCYTOSINE METHODS OF USE | 2017-01-19 |
20170014412 | OUTPATIENT MODIFIED RAPID DETOXIFICATION FOR ADDICTION TO ALCOHOL AND DRUGS | 2017-01-19 |
20170014413 | NOVEL KIF5B-RET FUSION MOLECULES AND USES THEREOF | 2017-01-19 |
20170014414 | PHARMACEUTICAL COMPOSITION | 2017-01-19 |
20170014415 | THIENO- AND PYRROLOPYRIMIDINE ANALOGUES AS ANTICANCER AGENTS AND METHODS OF USE THEREOF | 2017-01-19 |
20170014416 | Compositions And Methods For Treatment Of Psychiatric Disorders | 2017-01-19 |
20170014417 | PHARMACEUTICAL ADMINISTRATION SYSTEM FOR THE TRANSDERMAL APPLICATION OF VARDENAFIL | 2017-01-19 |
20170014418 | BICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS | 2017-01-19 |
20170014419 | MEDICAMENT FOR SUPPRESSING MALIGNANT TUMOR METASTASIS | 2017-01-19 |
20170014420 | USE OF NK-1 RECEPTOR ANTAGONISTS FOR TREATING HYPOMAGNESEMIA, NEUROGENIC INFLAMMATION, AND CARDIAC DYSFUNCTION ASSOCIATED WITH EGFR-BLOCKING DRUGS | 2017-01-19 |
20170014421 | PIPERAZINE PHENOTHIAZINE DERIVATIVES FOR TREATING SPASTICITY | 2017-01-19 |
20170014422 | PHARMACEUTICAL COMPOSITION COMPRISING IVABRADINE HYDROCHLORIDE POLYMORPH IV | 2017-01-19 |
20170014423 | Benzazepine Dicarboxamide Compounds | 2017-01-19 |
20170014424 | ADMINISTRATION OF ILOPROST AS AEROSOL BOLUS | 2017-01-19 |
20170014425 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATINGHEARING LOSS, COMPRISING CARBENOXOLONE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AS EFFECTIVE COMPOUND | 2017-01-19 |
20170014426 | ULIPRISTAL ACETATE FOR PREVENTION AND TREATMENT OF BREAST TUMORS | 2017-01-19 |
20170014427 | Composition and Method for Curing Migraine Headaches | 2017-01-19 |
20170014428 | INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CYCLODEXTRIN A HYDROPHOBIC DRUG, A CO-SOLVENT, AND A PRESERVATIVE | 2017-01-19 |
20170014429 | USES OF OXYGENATED CHOLESTEROL SULFATES (OCS) | 2017-01-19 |
20170014430 | Cycloartenol-Containing Composition | 2017-01-19 |
20170014431 | ROCURONIUM BROMIDE INJECTION SOLUTION-FILLED PREFILLED SYRINGE | 2017-01-19 |
20170014432 | COMPOSITIONS AND METHODS FOR REDUCING CHRONIC LOW-LEVEL INFLAMMATION | 2017-01-19 |
20170014433 | COMBINATION THERAPY FOR SKIN DISORDERS | 2017-01-19 |
20170014434 | Small Molecule HSP70 Inhibitors | 2017-01-19 |
20170014435 | USE OF THIOPYRIMIDINECARBOXAMIDE FOR TREATING CANCER | 2017-01-19 |
20170014436 | Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and type 2 diabetes. | 2017-01-19 |
20170014437 | SYNTHETIC DISUGAR HYDROCARBONS AS NATURAL ANALOGS TO CONTROL MICROBIAL BEHAVIORS | 2017-01-19 |
20170014438 | ANTI- ESOPHAGEAL CANCER COMPOUND AND METHOD OF USE THEREOF | 2017-01-19 |
20170014439 | FLAVONOID COMPOSITIONS AND USES THEREOF | 2017-01-19 |
20170014440 | COMPOSITIONS COMPRISING DECITABINE AND TETRAHYDROURIDINE AND USES THEREOF | 2017-01-19 |
20170014441 | INDUCTION OF THYROID IODIDE-HANDLING GENE EXPRESSION IN HUMAN CANCERS | 2017-01-19 |
20170014442 | METHOD FOR PREVENTION OF COLECTOMY | 2017-01-19 |
20170014443 | Compositions and methods for treating gastrointestinal disorders for humans and animal husbandry | 2017-01-19 |
20170014444 | AGENT FOR SEDATING RESPONSE TO EXTERNAL STIMULATION IN SKIN AND METHOD FOR SEDATING THAT RESPONSE | 2017-01-19 |
20170014445 | PECTIN BASED NANOPARTICLES | 2017-01-19 |
20170014446 | COMPOSITIONS AND METHODS FOR ADMINISTERING GALECTIN ANTAGONISTS | 2017-01-19 |
20170014447 | INHIBITION OF PANCREATIC LIPASE | 2017-01-19 |
20170014448 | BISMUTH(III) COMPLEXES AS ADJUVANTS IN THE TREATMENT OF CANCER USING PLATINUM-BASED CHEMOTHERAPY | 2017-01-19 |
20170014449 | SITE-SPECIFIC EPIGENETIC EDITING | 2017-01-19 |
20170014450 | BRAIN SPECIFIC EXOSOME BASED DIAGNOSTICS AND EXTRACORPOREAL THERAPIES | 2017-01-19 |
20170014451 | COMPOSITIONS AND METHODS OF TREATING T CELL MEDIATED DISORDER | 2017-01-19 |
20170014452 | COMPOSITIONS AND METHODS FOR TREATING PERITONEAL CANCERS | 2017-01-19 |
20170014453 | Enhancement of Allogeneic Hematopoietic Stem Cell Transplantation | 2017-01-19 |
20170014454 | SYSTEMIC, ALLOGENIC STEM CELL THERAPIES FOR TREATMENT OF DISEASES IN ANIMALS | 2017-01-19 |
20170014455 | INDUCING BROWN FAT FATE AND FUNCTION | 2017-01-19 |
20170014456 | METHODS AND SYSTEMS FOR ENDOMETRIAL TREATMENT | 2017-01-19 |
20170014457 | Bacteria Engineered to Reduce Hyperphenylalaninemia | 2017-01-19 |
20170014458 | MUCOADHESIVE SUSTAINED-RELEASE VAGINAL TABLET | 2017-01-19 |
20170014459 | TOPICAL COMPOSITIONS COMPRISING EXTRACT OF CORIOLUS VERSICOLOR FOR AUTOIMMUNITY ENHANCEMENT | 2017-01-19 |
20170014460 | INHIBITION OF HYPOXIA-INDUCIBLE FACTOR ACTIVITY WITH CARICA PAPAYA EXTRACTS | 2017-01-19 |
20170014461 | Compositions, Methods, and Medical Compositions for Treatment of and Maintaining the Health of the Liver | 2017-01-19 |
20170014462 | BONE AND JOINT PROTECTION COMPOSITION AND USE THEREOF | 2017-01-19 |
20170014463 | Composition Comprising Plants Extracts that Synergistically Treat or Inhibit Pathological Conditions and Method of Making | 2017-01-19 |
20170014464 | HERBAL COMPOSITION FOR BODY TREATMENT | 2017-01-19 |
20170014465 | USE OF ESCIN | 2017-01-19 |
20170014466 | ANTIOXIDANT ENRICHED DISTILLED ALCOHOL PRODUCT AND PROCESS THEREFOR | 2017-01-19 |
20170014467 | COMPOSITION AND THE USE THEREOF | 2017-01-19 |
20170014468 | METHODS OF USE FOR THERAPEUTICS TARGETING THE PATHOGEN PORPHYROMONAS GINGIVALIS | 2017-01-19 |
20170014469 | METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS | 2017-01-19 |
20170014470 | Sincalide Formulations | 2017-01-19 |
20170014471 | COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE | 2017-01-19 |
20170014472 | ATTENUATION OF INTRAPULMONARY INFLAMMATION | 2017-01-19 |